Evaluation of the Beneficial Effects of a Probiotic Product in Healthy Adult Subjects.
- Conditions
- DisbiosisConstipationAbdominal PainDiarrheaStress
- Registration Number
- NCT03234452
- Lead Sponsor
- Montefarmaco OTC SpA
- Brief Summary
A randomized, double-blind, placebo-controlled, cross-over trial performed at one centre in Italy to explore the ability of a multistrain probiotic mixture, to modulate markers of inflammation and intestinal barrier function and gastrointestinal symptoms in healthy volunteers with self-reported anxiety.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Eligible subjects were healthy men and women, 20-35 years old, with a STAI scale, form Y, module 1 (state anxiety) score of ≥ 35 and ≥40, for men and women, respectively.
Most important exclusion criteria were history or diagnosis of GI disease, oral antibiotics within 30 days prior to the screening visit, and use of drugs, food or herbal supplements for digestive symptoms.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method NK activity 45 days Verify that Natural Killer activities concentration is significantly higher in the experimental Group compared to the placebo group
- Secondary Outcome Measures
Name Time Method microbiota composition investigation 45 days Gastrointestinal symptoms (abdominal pain, aerophagia, diarrhea, constipation, diarrhea/constipation alternation ) 45 days IgA, IL8, TNF-Alpha, IL10 45 days Cortisol, alpha-amylase , chromogranin A 45 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Centro Ricerche Cliniche di Verona Srl,
🇮🇹Verona, (Vr), Italy
Centro Ricerche Cliniche di Verona Srl,🇮🇹Verona, (Vr), Italy